Reuters logo
BRIEF-Ra Pharmaceuticals initiates dosing of RA101495 in PNH patients
April 26, 2017 / 11:50 AM / in 6 months

BRIEF-Ra Pharmaceuticals initiates dosing of RA101495 in PNH patients

April 26 (Reuters) - Ra Pharmaceuticals Inc

* Ra Pharmaceuticals initiates dosing of ra101495 in PNH patients

* Ra Pharmaceuticals Inc says initial data from global phase 2 program expected mid-2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below